A community standard for immunogenomic data reporting and analysis: Proposal for a STrengthening the REporting of Immunogenomic Studies statement

Tissue Antigens

Volumn 78, Issue 5, 2011, Pages 333-344

  Hollenbach, J A ^a,b   Mack, S J ^a   Gourraud, P A ^c   Single, R M ^d   Maiers, M ^b   Middleton, D ^e   Thomson, G ^f   Marsh, S G E ^g   Varney, M D ^h  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Vermont   (United States)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^h AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Data analysis; Data management; Human leukocyte antigen; Killer cell Immunoglobulin like Receptor; Reporting guidelines; Standards; STrengthening the REporting of Genetic Association studies; STrengthening the REporting of Immunogenomic Studies; STrengthening the Reporting of OBservational studies in Epidemiology

Indexed keywords

HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; COMMUNITY; DATA ANALYSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENETICS; INFORMATION PROCESSING; NOTE; PHYLOGENY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD; STRENGTHENING THE REPORTING OF IMMUNOGENOMIC STUDIES GUIDELINE;

GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HLA ANTIGENS; HUMANS; RESEARCH DESIGN;

EID: 80053928599     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01777.x     Document Type: Note

References (51)

1. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007: 18: 800-4.
2. Little J, Higgins JP, Ioannidis JP et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet 2009: 125: 131-51.
3. Khoury MJ, Little J, Higgins J, Ioannidis JP, Gwinn M. Reporting of systematic reviews: the challenge of genetic association studies. PLoS Med 2007: 4: e211.
4. Khoury MJ, Little J, Gwinn M, Ioannidis JP. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 2007: 36: 439-45.
5. Khoury MJ, McBride CM, Schully SD et al. The scientific foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009: 11: 559-67.
6. Yesupriya A, Evangelou E, Kavvoura FK et al. Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol 2008: 8: 31.
7. Yesupriya A, Yu W, Clyne M, Gwinn M, Khoury MJ. The continued need to synthesize the results of genetic associations across multiple studies. Genet Med 2008: 10: 633-5.
8. Miretti MM, Beck S. Immunogenomics: molecular hide and seek. Hum Genomics 2006: 2: 244-51.
9. Helmberg W, Hegland J, Hurley CK, Maiers M, Marsh SGE, Müller C, Rozemuller EH. Going back to the roots: effective utilisation of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. Tissue Antigens 2000: 56: 99-102.
10. WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system, 1987. Tissue Antigens 1988: 32: 177-87.
11. WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HL-a system. Bull World Health Organ 1968: 39: 483-6.
12. WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system. Bull World Health Organ 1975: 52: 261-5.
13. WHO Nomenclature Committee for Factors of the HLA System. Nomenclature for factors of the HLA system-1977. Tissue Antigens 1978: 11: 81-6.
14. Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens 1992: 39: 161-73.
15. Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 2002: 60: 407-64.
16. Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010: 75: 291-455.
17. Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA system, 1990. Tissue Antigens 1991: 37: 97-104.
18. Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA System, 1998. Hum Immunol 1999: 60: 361-95.
19. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE. IMGT/HLA - a sequence database for the human major histocompatibility complex. Tissue Antigens 2000: 55: 280-7.
20. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2011: 39: D1171-6.
21. Meyer D, Mack SJ. Major histocompatibility complex (MHC) genes: polymorphism. Encyclopedia of Life Sciences. Chichester: John Wiley & Sons, Ltd, 2008.
22. Iafrate AJ, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat Genet 2004: 36: 949-51.
23. Klein J, Figueroa F. Evolution of the major histocompatibility complex. Crit Rev Immunol 1986: 6: 295-386.
24. Hurley CK, Setterholm M, Lau M et al. Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Bone Marrow Transplant 2004: 33: 443-50.
25. European Federation for Immunogenetics. Standards for PROVIDERS of external proficiency testing (EPT) schemes - version 5.0. (accessed 5 April 2011).
26. Nunes E, Heslop H, Fernandez-Vina M et al. Definitions of histocompatibility typing terms: harmonization of histocompatibility typing terms working group. Hum Immunol 2011 (in press).
27. Noble JA, Valdes AM, Varney MD et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010: 59: 2972-9.
28. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: Tissue Antigens 2003: 61: 403-7.
29. Cano P, Klitz W, Mack SJ et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the American society for histocompatibility and immunogenetics. Hum Immunol 2007: 68: 392-417.
30. Middleton D, Gonzalez F, Fernandez-Vina M et al. A bioinformatics approach to ascertaining the rarity of HLA alleles. Tissue Antigens 2009: 74: 480-5.
31. *1454 in South German Caucasians. Tissue Antigens 2010: 76: 57-9.
32. *1454. Int J Immunogenet 2009: 36: 119-20.
33. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002: 190: 40-52.
34. Martin AM, Kulski JK, Gaudieri S et al. Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 2004: 335: 121-31.
35. Vilches C, Pando MJ, Rajalingam R, Gardiner CM, Parham P. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. Tissue Antigens 2000: 56: 453-6.
36. Middleton D, Meenagh A, Gourraud PA. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 2007: 59: 145-58.
37. Robinson J, Mistry K, McWilliam H, Lopez R, Marsh SG. IPD-the Immuno Polymorphism Database. Nucleic Acids Res 2010: 38: D863-9.
38. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007: 81: 559-75.
39. Wang J, Ronaghi M, Chong SS, Lee CG. pfSNP: an integrated potentially functional SNP resource that facilitates hypotheses generation through knowledge syntheses. Hum Mutat 2011: 32: 19-24.
40. Farewell VT, Dahlberg S. Some statistical methodology for the analysis of HLA data. Biometrics 1984: 40: 547-60.
41. Thomson G, Maldonado-Torres H, Lancaster AK et al. Hardy-Weinberg proportions methods manual version 0.1.2: testing fit of genotype frequencies to Hardy-Weinberg proportions. 2009.
42. Thomson G, Barcellos LF, Valdes AM. Searching for additional disease loci in a genomic region. Adv Genet 2008: 60: 253-92.
43. Single RM, Martin MP, Meyer D, Gao X, Carrington M. Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 2008: 60: 711-25.
44. Gourraud PA, Meenagh A, Cambon-Thomsen A, Middleton D. Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics 2010: 62: 729-40.
45. Single RM, Meyer D, Thomson G. Statistical methods for analysis of population genetic data. In: Hansen JA, ed. Immunobiology of the Human MHC Proceedings of the 13th International Histocompatibility Workshop and Conference. Seattle: IHWG Press, 2007.
46. Mack SJ, Sanchez-Mazas A, Meyer D, Single RM, Tsai Y, Erlich HA. Methods used in the generation and preparation of data for analysis in the 13th International Histocompatibility Workshop. 13th International Histocompatibility Workshop Anthropology/Human Genetic Diversity Joint Report. In: Hansen JA, ed. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference., Seattle: IHWG Press, 2007.
47. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P. Association mapping in structured populations. Am J Hum Genet 2000: 67: 170-81.
48. Robinson J, Waller MJ, Fail SC, Marsh SG. The IMGT/HLA and IPD databases. Hum Mutat 2006: 27: 1192-9.
49. Vandiedonck C, Knight JC. The human major histocompatibility complex as a paradigm in genomics research. Brief Funct Genomic Proteomic 2009: 8: 379-94.
50. Fairbairn DJ. The advent of mandatory data archiving. Evolution 2011: 65: 1-2.
51. Discussing standards. Nat Genet 2010: 42: 915.